细胞分化
细胞培养
生物
糖
生物化学
细胞生物学
基因
遗传学
作者
A Zweibaum,Moı̈se Pinto,Guillemette Chevalier,Elisabeth Dussaulx,N Triadou,Brigitte Lacroix,K Haffen,J.-F. Brun,Monique Rousset
标识
DOI:10.1002/jcp.1041220105
摘要
Abstract In order to study the effect of glucose on the differentiation of cultured human colon cancer cells, a subpopulation of HT‐29 cells was selected for its capacity to grow in the total absence of sugar. These cells (GIc − cells) exhibit, after confluency, an enterocytic differentiation, in contrast to cells grown with glucose (Glc + cells), which always remain undifferentiated. The differentiation is characterized by a polarization of the cell layer with apical brush borders and tight junctions, and by the presence of sucrase‐isomaltase. The differentiation of Glc − cells is reversible: the addition of glucose to postcon‐fluent cultures of Glc − cells results in an inhibiting effect on the expression of sucrase‐isomaltase; switching growing cultures of Glc − cells to the Glc + medium for several passages results in a progressive reversion to the undifferentiated state, which is completed after seven passages. The dedifferentiation process is associated with a parallel, passage‐related, increase in the rates of glucose consumption and lactic acid production, and decreases of intracellular glycogen content, which return to the values of the undifferentiated original Glc + cells. The values of these metabolic parameters are correlated, at each passage, with the degree of dedifferentiation of the cells. When these dedifferentiated cells, after having been cultured in Glc + medium for 20 passages, are switched back to the Glc − medium, they readily grow without mortality, and reexpress the same enterocytic differentiation as the parent Glc − cells. These results show that the capacity of this subpopulation to grow and differentiate in the absence of sugar is a stable characteristic. They further suggest that glucose metabolism interferes with the program of differentiation of HT‐29 cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI